Kyverna Therapeutics, Inc.

Direct answer

Kyverna Therapeutics, Inc. is publicly traded on NASDAQ under the ticker KYTX.

Kyverna Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the advancement of cell-based therapies to treat individuals suffering from autoimmune disorders. Its primary experimental therapy, KYV-101, an autologous CD19 CAR T-cell candidate, is currently undergoing Phase I clinical evaluation for lupus nephritis and systemic sclerosis, and has progressed to Phase II studies for...

Can you invest in Kyverna Therapeutics, Inc.?

Yes. Kyverna Therapeutics, Inc. trades publicly on NASDAQ as KYTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Kyverna Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.